Merck | MRK - Operating Expenses


Merck reported EUR4.09B in Operating Expenses for its fiscal quarter ending in March of 2026.





Operating Expenses Change Date
Adidas EUR 5.89B 25M Mar/2026
Adyen EUR 795.29M 28.84M Dec/2025
Akzo Nobel EUR 2.13B 23M Mar/2026
Alcon AG USD 2.41B 4M Mar/2026
Amadeus IT EUR 1.19B 91.3M Mar/2026
Amarin USD 51.48M 113K Dec/2025
AstraZeneca USD 8.18B 4.35B Mar/2026
BASF EUR 14.62B 410M Mar/2026
Bayer EUR 9.88B 452M Mar/2026
Beiersdorf EUR 4.16B 212M Dec/2025
Covestro EUR 3.24B 5.46B Dec/2025
Danone EUR 11.68B 239M Dec/2025
Fresenius EUR 5.25B 337M Dec/2025
Fresenius Medical Care EUR 4.34B 63M Mar/2026
Genmab DKK 798M 235M Dec/2025
Givaudan CHF 3B 107M Dec/2025
GlaxoSmithKline GBP 5.34B 1.85B Mar/2026
GRIFOLS EUR 1.45B 255.28M Mar/2026
Henkel EUR 8.67B 122M Dec/2025
Hikma Pharmaceutical USD 1.34B 702M Dec/2025
Infineon EUR 3.33B 53M Mar/2026
Lakefront Biotherapeutics EUR 70.18M 50.08M Mar/2026
Linde USD 6.52B 309M Dec/2025
Lonza CHF 2.9B 184M Jun/2025
Merck EUR 4.09B 687M Mar/2026
Novartis USD 9.29B 507M Mar/2026
Philips EUR 3.6B 775M Mar/2026
Roche Holding CHF 21.01B 10.84B Dec/2025
Sanofi EUR 9.31B 1.2B Mar/2026
UCB EUR 2.96B 196M Dec/2025